EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study

Tara Sanft iD, Maura Harrigan, Courtney McGowan, Brenda Cartmel iD, Michelle Zupa iD, Fang-Yong Li iD, Leah M Ferrucci iD, Leah Puklin iD, Anlan Cao iD, Thai Hien Nguyen, Marian L Neuhouser, Dawn L Hershman iD und 8 weitere

Journal of Clinical Oncology · 01.12.2023 · 41 (34) · 5285-5295

DOI: 10.1200/jco.23.00871 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.12.2023. Verfasst von Tara Sanft und 19 weiteren Autor:innen. Beteiligte Einrichtung: Yale University School of Medicine, New Haven, CT. Hauptthemen laut MEDLINE: Breast Neoplasms, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Successful completion of chemotherapy is critical to improve breast cancer outcomes. Relative dose intensity (RDI), defined as the ratio of chemotherapy delivered to prescribed, is a measure of chemotherapy completion and is associated with cancer mortality. The effect of exercise and eating a healthy diet on RDI is unknown. We conducted a randomized trial of an exercise and nutrition intervention on RDI and pathologic complete response (pCR) in women diagnosed with breast cancer initiating chemotherapy. METHODS One hundred seventy-three women with stage I-III breast cancer were randomly assigned to usual care (UC; n = 86) or a home-based exercise and nutrition intervention with counseling sessions delivered by oncology-certified registered dietitians (n = 87). Chemotherapy dose adjustments and delays and pCR were abstracted from electronic medical records. T-tests and chi-square tests were used to examine the effect of the intervention versus UC on RDI and pCR. RESULTS Participants randomly assigned to intervention had greater improvements in exercise and diet quality compared with UC ( P < .05). RDI was 92.9% ± 12.1% and 93.6% ± 11.1% for intervention and UC, respectively ( P = .69); the proportion of patients in the intervention versus UC who achieved ≥85% RDI was 81% and 85%, respectively ( P = .44). The proportion of patients who had at least one dose reduction and/or delay was 38% intervention and 36% UC ( P = .80). Among 72 women who received neoadjuvant chemotherapy, women randomly assigned to intervention were more likely to have a pCR than those randomly assigned to UC (53% v 28%; P = .037). CONCLUSION Although a diet and exercise intervention did not affect RDI, the intervention was associated with a higher pCR in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative and triple-negative breast cancer undergoing neoadjuvant chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsTriple Negative Breast NeoplasmsHumansFemaleExerciseNutritional StatusDietLife Style

Autor:innen und Institutionen

  • Yale University School of Medicine, New Haven, CT.
  • Yale Cancer Center, New Haven, CT.
  • Yale School of Public Health, New Haven, CT.
  • Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Columbia University Medical Center, New York, NY.
  • The University of Texas MD Anderson Cancer Center, Houston, TX.

ORCID-Profile: Tara Sanft, Brenda Cartmel, Michelle Zupa, Fang-Yong Li, Leah M Ferrucci, Leah Puklin, Anlan Cao, Dawn L Hershman, Karen Basen-Engquist, Anees B Chagpar, Andrea Silber, Jennifer A Ligibel, Melinda L Irwin

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Sanft, T., Harrigan, M., McGowan, C., Cartmel, B., Zupa, M., Li, F. Y., Ferrucci, L. M., Puklin, L., Cao, A., Nguyen, T. H., Neuhouser, M. L., Hershman, D. L., Basen-Engquist, K., Jones, B. A., Knobf, T., Chagpar, A. B., Silber, A., Tanasijevic, A., Ligibel, J. A., & Irwin, M. L. (2023). Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal of Clinical Oncology, 41(34), 5285-5295. https://doi.org/10.1200/jco.23.00871

Vancouver

Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li FY, et al. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal of Clinical Oncology. 2023;41(34):5285-5295. doi:10.1200/jco.23.00871

BibTeX
@article{Sanft2023,
  author = {Sanft, Tara and Harrigan, Maura and McGowan, Courtney and Cartmel, Brenda and Zupa, Michelle and Li, Fang-Yong and Ferrucci, Leah M and Puklin, Leah and Cao, Anlan and Nguyen, Thai Hien and Neuhouser, Marian L and Hershman, Dawn L and Basen-Engquist, Karen and Jones, Beth A and Knobf, Tish and Chagpar, Anees B and Silber, Andrea and Tanasijevic, Anna and Ligibel, Jennifer A and Irwin, Melinda L},
  title = {Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study},
  journal = {Journal of Clinical Oncology},
  year = {2023},
  volume = {41},
  number = {34},
  pages = {5285--5295},
  doi = {10.1200/jco.23.00871}
}
Kostenlos starten →